CSF1 and triple-negative breast carcinoma: This work implicates a role for the CSF1 enhancer in the progression of triple-negative breast cancer and potentially other cancer types, highlighting the eRNA transcripts and associated downstream genes as potential targets for the therapeutic intervention.